Having a mother with Alzheimer’s disease appears to raise your risk more than having a father with it, but the full picture is far messier than that headline suggests. Multiple brain-imaging studies have found that cognitively healthy adults with a maternal history of Alzheimer’s carry higher levels of amyloid plaque, one of the disease’s hallmark proteins, than those with only a paternal history. Yet Alzheimer’s is not a single-gene, single-parent disease. It involves dozens of genetic variants, epigenetic quirks that change how those genes behave depending on which parent they came from, and lifestyle factors that can shift risk substantially in either direction.
What Brain Scans Show About Maternal vs. Paternal History
The strongest evidence for a maternal tilt comes from imaging studies that measure amyloid-beta, a sticky protein that accumulates in the brains of people with Alzheimer’s years or even decades before symptoms appear. A 2024 study of over 4,400 cognitively unimpaired older adults found that people whose mothers had memory impairment showed higher amyloid levels on PET scans than those whose fathers were affected. The maternal-history group had a statistically significant elevation in amyloid, while the paternal-history group did not differ meaningfully from people with no family history at all.1JAMA Neurology. Parental History of Memory Impairment and β-Amyloid in Cognitively Unimpaired Older Adults Individuals who had both parents affected showed the highest amyloid burden of all.
Earlier work pointed in the same direction. A study examining cerebrospinal fluid markers and PET imaging found that people with a maternal family history of dementia had significantly more amyloid in several brain regions, including the parietal cortex and precuneus, compared to those with no family history. People with a paternal history did not show the same elevation.2PubMed Central. Maternal Family History is Associated with Alzheimer’s Disease Biomarkers Separate PET research using a glucose-metabolism tracer showed that cognitively normal people with a maternal history of late-onset Alzheimer’s had progressive reductions in brain glucose metabolism resembling the pattern seen in actual Alzheimer’s patients, while those with a paternal history did not.3PubMed Central. Maternal transmission of Alzheimer’s disease: prodromal metabolic phenotype and the search for genes
These findings are striking, but they describe averages across study populations. Having a father with Alzheimer’s does not mean your risk is zero, and having a mother with it does not make Alzheimer’s inevitable. The biomarker differences are real but modest in size, and many people with elevated amyloid never develop symptoms in their lifetimes.
Three Reasons the Maternal Signal Is Stronger
Researchers have proposed several biological mechanisms to explain why maternal inheritance might carry extra weight. Each one is plausible, but none has been definitively proven to be the main driver, and they are not mutually exclusive.
Mitochondrial DNA
You inherit your mitochondria, the energy-producing structures inside cells, exclusively from your mother. Mitochondrial DNA is a small, separate genome that encodes proteins essential for cellular energy production. If variants in mitochondrial DNA contribute to Alzheimer’s risk, the effect would be transmitted only through the maternal line. A large-scale analysis of whole-genome sequencing data from roughly half a million UK Biobank participants found suggestive associations between mitochondrial DNA variants and Alzheimer’s-related phenotypes, including variants in genes encoding key enzymes in the mitochondrial energy chain that had previously been found to be overexpressed in the blood of people with early-stage Alzheimer’s.4Alzheimer’s & Dementia. Association of mitochondrial DNA variants with Alzheimer’s disease phenotypes in 500K participants with whole genome sequencing from the UK Biobank The associations were suggestive rather than definitive, meaning this line of research has not yet produced a smoking gun. But the logic is compelling: if the brain’s energy supply is compromised by inherited mitochondrial variation, it could accelerate the accumulation of toxic proteins over a lifetime.
Genomic Imprinting
Most of your genes come in two copies, one from each parent, and both copies are usually active. But some genes are “imprinted,” meaning the copy from one parent is chemically silenced so that only the other parent’s copy is expressed. If an imprinted gene relevant to Alzheimer’s is active only when inherited from the mother, a risk variant on that gene would matter only if it came from her. Researchers have identified several imprinted genes with significant associations with late-onset Alzheimer’s, including genes expressed specifically in the brain.5PubMed Central. Genetic Variation in Imprinted Genes is Associated with Risk of Late-Onset Alzheimer’s disease Linkage studies have reinforced this idea: when researchers looked for chromosomal regions tied to Alzheimer’s risk and split families by whether the disease came from the mother or the father, different chromosomal regions lit up for each group. Maternal families showed strong signals on chromosomes 10 and 12, while paternal families flagged regions on chromosomes 1, 7, and 13. In many cases, analyzing parent-of-origin separately revealed linkage that was invisible when all families were pooled together.6PubMed. Evidence for parent of origin effect in late-onset Alzheimer disease
The X Chromosome
Mothers always contribute an X chromosome, while fathers contribute either an X or a Y. Since women have two X chromosomes and men have one, some researchers have wondered whether X-linked genetic variants might contribute to both the maternal inheritance pattern and the higher prevalence of Alzheimer’s in women. However, a well-powered X-chromosome-wide association study found no significant genetic risk factors for Alzheimer’s on the non-pseudoautosomal region of the X chromosome, though it did flag some signals worth investigating further.7Molecular Psychiatry. X-chromosome-wide association study for Alzheimer’s disease For now, the X chromosome does not appear to be a major player in explaining the maternal tilt.
Paternal History Still Matters
The emphasis on maternal inheritance can create a misleading impression that fathers are irrelevant. They are not. A large family-history study found mixed evidence for differences in risk based on maternal vs. paternal inheritance. While some analyses favored a maternal effect, the study also found that having at least one affected first-degree relative of either sex increased risk, and that men with equivalent family histories appeared to face higher risk than women.8PubMed Central. Relative risk for Alzheimer disease based on complete family history Cumulative risk estimates suggest the offspring of someone with Alzheimer’s face roughly 20 to 65 percent higher risk of developing dementia themselves compared to people with no family history, regardless of which parent was affected.9PubMed Central. Parent-of-origin effects in Alzheimer’s liability dissociate neurocognitive and cardiovascular traits in at-risk individuals
There is also intriguing evidence that paternal contributions operate through their own distinct pathways. Brain imaging research has identified specific paternal effects on hippocampal structures, the brain region most associated with memory. These effects were lateralized to the left hemisphere and differed between sons and daughters, suggesting that paternal genetic contributions shape Alzheimer’s vulnerability in ways that maternal-focused studies tend to overlook.9PubMed Central. Parent-of-origin effects in Alzheimer’s liability dissociate neurocognitive and cardiovascular traits in at-risk individuals One older study even found that younger paternal age at conception was associated with higher susceptibility to late-onset Alzheimer’s, an effect the authors attributed to a possible imprinting mechanism involving DNA methylation patterns that change as men age.10JAMA Neurology. Association of Decreased Paternal Age and Late-Onset Alzheimer’s Disease: An Example of Genetic Imprinting?
The APOE Connection
APOE is the single most influential common gene variant for late-onset Alzheimer’s risk. Carrying one copy of the APOE e4 version of this gene increases your risk considerably; carrying two copies increases it more. What makes APOE relevant to the maternal-vs.-paternal question is that among Alzheimer’s patients who carry APOE e4, inheritance from the mother is more common than from the father.11PubMed. Alzheimer’s disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset This does not mean APOE e4 only matters when it comes from your mother. You can inherit it from either parent, and it raises risk regardless. But the interaction between APOE e4 status and maternal history suggests that the genetic mechanisms behind the maternal effect may amplify or interact with the most common genetic risk factor rather than operating independently of it.
When researchers build polygenic risk scores that try to predict Alzheimer’s likelihood from many genetic variants combined, adding family history information on top of the genetic score improves accuracy. In one analysis, a joint predictor combining genetic data with family history improved reclassification accuracy by about 6 percent over genetic data alone, and the joint score was significantly associated with carrying APOE e4 alleles even though APOE was not directly included in the polygenic score calculation.12PubMed Central. Capturing additional genetic risk from family history for improved polygenic risk prediction In practical terms, knowing your family history adds meaningful information beyond what a DNA test alone can tell you.
A Mouse Study That Complicates the Narrative
If maternal inheritance were the dominant biological force, you might expect animal models to show the same pattern. A recent study in 5xFAD mice, a commonly used Alzheimer’s model, found the opposite: paternal inheritance of the Alzheimer’s-linked transgene led to roughly twice the amyloid plaque burden compared to maternal inheritance. The researchers ruled out the possibility that being gestated or nursed by an affected mother somehow suppressed plaque formation; the effect appeared to be driven by genomic imprinting of the gene’s promoter region, causing higher protein expression when the gene came from the father.13PubMed. Parental origin of transgene modulates amyloid-β plaque burden in the 5xFAD mouse model of Alzheimer’s disease
This does not overturn the human data showing a maternal tilt. Mouse transgene models are artificial by design, and the imprinting of a synthetic transgene may not mirror natural human gene regulation. But the finding serves as a useful reminder that parent-of-origin effects can push risk in either direction depending on the specific gene and its regulatory context. The human evidence for maternal predominance is real, but it exists alongside paternal-origin effects that operate through different mechanisms and in different brain regions.
Why Family History Data Can Be Misleading
Before taking the maternal signal at face value, it is worth considering a few sources of bias. Women live longer than men on average, and Alzheimer’s risk rises sharply with age. A mother is simply more likely to survive long enough to develop and be diagnosed with dementia than a father who dies of cardiovascular disease at 68. If your father died before he had the chance to develop Alzheimer’s, his genetic contribution to your risk remains hidden.
Reporting bias compounds this issue. In research cohorts, about 40 percent of participants report dementia in at least one parent, but around 8 percent say they do not know their parents’ cognitive status. Those who report no parental dementia or unknown history tend to be older, less educated, and more likely to belong to underrepresented racial and ethnic groups. They are also more likely to be missing APOE genetic data and to already have cognitive impairment themselves at the time they enter a study.14IOS Press / PubMed Central. Potential biases associated with reported parental history of dementia in the Alzheimer’s Disease Research Center cohorts: Implications for secondary data analyses All of this means that the maternal-vs.-paternal comparisons in many studies may be working with incomplete and systematically skewed data. Fathers’ histories are more likely to be missing or unknown, which could artificially inflate the apparent maternal effect.
Early-Onset vs. Late-Onset Alzheimer’s
The maternal-vs.-paternal question mainly applies to late-onset Alzheimer’s, the common form that appears after age 65. Early-onset Alzheimer’s, striking before 65, follows different rules. It is more often caused by rare mutations in specific genes, APP, PSEN1, and PSEN2, that follow standard inheritance patterns and can come equally from either parent.15PubMed Central. Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin? If a parent carried one of these mutations, each child has a 50 percent chance of inheriting it regardless of whether the affected parent is the mother or the father. Early-onset Alzheimer’s is much rarer, accounting for roughly 5 to 10 percent of all cases, but it tends to run more obviously in families and progress more aggressively.
For late-onset Alzheimer’s, where no single gene dictates the outcome, the maternal signal from imaging studies reflects a statistical tendency across populations. It does not mean that any individual person’s risk is determined by which parent developed the disease.
Microchimerism and Other Frontier Research
One of the more surprising areas of investigation involves microchimerism, the persistence of a small number of cells from one individual in another’s body. During pregnancy, cells cross the placenta in both directions. Maternal cells have been found in offspring brains in experimental models, where they adopt neural and immune-cell characteristics.16PubMed Central. Feto-Maternal Microchimerism and the Brain: Mechanisms, Neurological Implications, and Translational Perspectives Whether these maternal cells influence the offspring’s long-term vulnerability to neurodegeneration remains unknown. The possibility is fascinating but entirely unproven as a mechanism for Alzheimer’s transmission. It represents the kind of question that may take another decade of research to resolve.
What You Can Actually Do With This Information
If your mother had Alzheimer’s, you may have somewhat higher biological risk markers than if your father had it. But “somewhat higher markers on a PET scan” is not the same as a diagnosis. And the risk from having an affected father is not negligible. The most honest summary of the current science is that maternal history carries a slightly stronger statistical association with preclinical biomarkers, but both parents contribute genetic risk through overlapping and distinct pathways.
The more actionable finding involves lifestyle. Research presented at an American Heart Association conference found that people with a family history of dementia who followed at least three healthy lifestyle behaviors, things like regular physical activity, a healthy diet, moderate alcohol use, and not smoking, had a 25 to 35 percent lower risk of dementia compared to those with similar family histories who followed fewer healthy behaviors.17American Heart Association Newsroom. Healthy lifestyle behaviors reduced dementia risk despite family history of dementia That effect size is large enough to matter, and it applied regardless of which parent was affected. Genetics loads the gun, as the saying goes, but it does not always pull the trigger.
For people considering genetic counseling, formal guidelines exist for assessing familial Alzheimer’s risk and deciding whether genetic testing makes sense. Testing is most informative for early-onset cases where a single-gene mutation may be identifiable. For late-onset Alzheimer’s, testing for APOE e4 can provide some risk information, but because many other genes and environmental factors are involved, a positive result does not guarantee disease and a negative result does not guarantee protection. Talking through what the results would mean for your decisions, and whether you actually want to know, is a conversation worth having with a genetic counselor before ordering a test.